Shares of Winsford, Chesire-based wound care firm Advanced Medical Solutions Group (AMS) rose 4% after it said its 2017 revenue rose 16% to £96.9 million and profit before tax jumped 32% to £25.3 million.

AMS CEO Chris Meredith said the firm is actively reviewing merger opportunities.

AMS shares have soared more than 40% in the past year to give it a current stock market value of roughly £700 million.

Meredith said: “This has been another year of good growth across the group and we are well positioned to take advantage of market opportunities across our product portfolio.

“Innovation is at the heart of our strategy and this allows us to maintain the high quality of our products that offer benefits to both patients and payors.

“Alongside our organic growth plan, AMS is actively reviewing M&A opportunities that will further increase value for shareholders.

“We look to the future with continued confidence.”